Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,727
Closed -$131K 959
2026
Q1
$131K Buy
1,727
+3
+0.2% +$226 0.03% 172
2025
Q4
$128K Hold
1,724
0.04% 157
2025
Q3
$116K Hold
1,724
0.03% 178
2025
Q2
$112K Sell
1,724
-758
-31% -$45.4K 0.04% 171
2025
Q1
$153K Buy
2,482
+758
+44% +$50.2K 0.06% 137
2024
Q4
$124K Hold
1,724
0.05% 155
2024
Q3
$140K Hold
1,724
0.06% 138
2024
Q2
$128K Hold
1,724
0.06% 136
2024
Q1
$134K Hold
1,724
0.08% 145
2023
Q4
$123K Buy
+1,724
New +$120K 0.08% 143

Other funds holding HOLX

Tidemark's HOLX Position: Q2 2026 in Review

Tidemark sold out of Hologic (HOLX) in Q2 2026, closing a stake of 1,727 shares — an estimated $131K sold.

Tidemark first reported a position in HOLX in Q4 2023 and held it in 10 quarters. The position peaked at $153K in Q1 2025. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Tidemark reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Tidemark sold 1,727 Hologic shares in Q2 2026, an estimated $131K.
  • Tidemark first reported a position in Hologic in Q4 2023 and held it in 10 quarters.
  • Tidemark's Hologic position peaked at $153K in Q1 2025.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Tidemark's 13F filing for Q2 2026, filed 10 Aug 2026.